The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study by Lev‐Ari, Shaked, Serzan, Michael, Wu, Tianmin, Ip, Andrew, Pascual, Lauren, Sinclaire, Brittany, Adams, Shari, Marafelias, Michael, Ayyagari, Lakshmi, Gill, Sarvarinder K., Ma, Barbara, Zaemes, Jacob P., Della Pia, Alexandra, Alaoui, Adil, Madhavan, Subha, Belouali, Anas, Pecora, Andrew, Ahn, Jaeil, Atkins, Michael B., Shah, Neil J.

Get full text

615 The impact of gender including female menopausal status on the safety and efficacy of immune checkpoint inhibitors by Ari, Shaked Lev, Zaemes, Jacob, Ozisik, Deniz, Zemel, Rachel A, Tan, Ming, Pascual, Lauren, Sinclaire, Brittany, Alaoui, Adil, DellaPia, Alexandra, Pecora, Andrew, Atkins, Michael B, Ip, Andrew, Shah, Neil J

Get full text

1317 Enhancing patient safety in melanoma treatment: harnessing machine learning for predicting immune-related adverse events by Zhang, Yili, Ari, Shaked Lev, Gupta, Samir, Zaemes, Jacob, Shah, Neil J, Alaoui, Adil, Madhavan, Subha, McGarvey, Peter, Atkins, Michael B

Get full text

1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan by Zaemes, Jacob, Ari, Shaked Lev, Pascual, Lauren, Jegede, Opeyemi A, Arias-Orozco, Natali, Sinclaire, Brittany, DellaPia, Alexandra, Zemel, Rachel A, Zhang, Yili, Gupta, Samir, Alaoui, Adil, Ip, Andrew, Atkins, Michael B, Regan, Meredith, Shah, Neil J

Get full text

Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review by David, Adi, Lev-Ari, Shaked

Get full text

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy by Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.

Get full text

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma by Asher, Nethanel, Ben-Betzalel, Guy, Lev-Ari, Shaked, Shapira-Frommer, Ronnie, Steinberg-Silman, Yael, Gochman, Neta, Schachter, Jacob, Meirson, Tomer, Markel, Gal

Get full text

Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials by Shah, Neil J, Della Pia, Alexandra, Wu, Tianmin, Williams, Aquino, Weber, Melinda, Sinclaire, Brittany, Gourna Paleoudis, Elli, Alaoui, Adil, Lev-Ari, Shaked, Adams, Shari, Kaufman, Jordan, Parikh, Sahil B, Tonti, Emily, Muller, Eric, Serzan, Michael, Cheruku, Divya, Lee, Albert, Sridhar, Aishwarya, Hee, Benjamin Thor Perrin, Ahn, Jaeil, Pecora, Andrew, Ip, Andrew, Atkins, Michael B

Get full text

Ocular injuries associated with two-wheeled electric transportation devices and motorcycle accidents by Lev Ari, Omer, Shaked, Gad, Michael, Tal, Givon, Adi, Bodas, Moran, Tsumi, Erez

Get full text